GSK Investigational Site

Sátoraljaújhely 3980

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Diabetes Mellitus, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed